Description

Albutein Human Albumin 20% is derived from large pools of carefully screened donor plasma and processed via ethanol fractionation, ultrafiltration, and pasteurization steps to yield ??95% human serum albumin purity. The 20% solution delivers robust oncotic pressure with lower electrolyte load, while maintaining fluid-shifting homeostasis. Widely used as a research-grade plasma substitute to model hypovolemia restoration, hypoalbuminemia correction, drug-binding dynamics, and colloid transport systems in both in vitro and in vivo studies. Packaged as a single 50?ml vial containing 10?g albumin. Strictly for laboratory research use.

Product Specifications

Mechanism of Action & Research Applications

Human albumin contributes significantly to colloid osmotic pressure, stabilizes circulating blood volume, and serves as a carrier for hormones, fatty acids, bilirubin, drugs, and toxins. In laboratory research, Albutein is commonly used to simulate plasma volume expansion, correct hypoalbuminemia, model drug-binding kinetics, study capillary fluid exchange, and investigate antioxidant or anti?inflammatory properties. It is also valuable for in vitro assays exploring protein-ligand binding and in vivo models of critical illness or sepsis. For research use only.

Side Effects (For Reference Only in Research Models)

Experimental or clinical analogs may include transient elevation of blood pressure, fluid overload, allergic reactions, nausea, headache, or rare thrombotic events. These are dose-dependent and provide reference for experimental safety design. Monitoring parameters such as hemodynamics and electrolytes is advised during assay or in vivo modeling. grifols.comdrugs.com

Disclaimer

Albutein Human Albumin 20% is strictly intended for laboratory research use only. Not for human or veterinary therapeutic or diagnostic use.